Health
Ascensia Diabetes Care And Its Employees Excited To Support Spare A Rose Campaign For The Fourth Consecutive Year
BASEL, Switzerland, Feb. 11, 2021 /PRNewswire/ -- Ascensia Diabetes Care, a leading global diabetes care company and the maker of the CONTOUR® range of blood glucose monitoring systems, has once again decided to support the Spare A Rose campaign, organized by Life for a Child, for the fourth cons...
Firmenich Reports Solid Half Year Results despite Pandemic
Delivering sustained revenue and free cash flow growth, while demonstrating resilient profitability. Integrating largest-ever acquisition. GENEVA, Feb. 11, 2021 /PRNewswire/ -- Firmenich International SA, the world's largest privately-owned Perfume and Taste company, announced its Half Year Resu...
Zymo Research Launches COVID-19 Sequencing Service for the Detection and Surveillance of Emerging SARS-CoV-2 Variants
Rapid reporting at high throughput enables detection of potential vaccine escaping variant strains IRVINE, Calif., Feb. 11, 2021 /PRNewswire/ -- Zymo Research announced today theirCOVID-19 Variant Sequencing Service. This new global service expands Zymo Research's end-to-end SARS-CoV-2 solutions...
Positivity Around Vaccine Roll-Out and Future Availability Leads to Improved Perceptions on Whole Health
HONG KONG, Feb. 11, 2021 /PRNewswire/ -- Cigna's (NYSE:CI) International Markets business today published the fifth edition of its COVID-19 Global Impact Study, which highlights the contrast in well-being around the world as vaccine roll-out commenced for some, while other markets anticipated vac...
Transcenta Holding Announces Appointment of Dr. Michael Shi as Executive Vice President, Head of Global R&D and Chief Medical Officer
SUZHOU, China, Feb. 10, 2021 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced the appointment of Dr.Michael Shi as Executive Vic...
First Patient Enrolled in SELUTION SLR(TM) SUCCESS PTA Study
NYON, Switzerland, Feb. 11, 2021 /PRNewswire/ -- MedAlliance has announced enrolment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon SELUTION SLR™ for the treatment of patients with peripheral artery disease (PAD). SELUTION SLR is a novel sirolimus-e...
'Supercharger' to revive mainstay antibiotic in global fight against antibiotic resistance
MELBOURNE, Australia, Feb. 11, 2021 /PRNewswire/ -- SuperTrans Medical (STM), a biopharmaceutical company developing novel antibiotics that target difficult-to-treat, multi-drug resistant bacteria, has published First-In-Class, successful pre-clinical results and announced plans to begin clinica...
ICP DAS Biomedical Polymers Announces To Offer Taiwan High-Quality Medical TPU
TAIPEI, Feb, 11, 2021 /PRNewswire/ -- ICP DAS- Biomedical Polymers ("ICP
DAS-BMP") is a medical TPU supplier inTaiwan. Today, the company officially
announced that it begins to offer its medical thermoplastic polyurethane (TPU)
to the medical devices market worldwide.
Care Journey Orchestration Tackles Healthcare's Biggest Operational Challenges
This innovative approach, already used in other industries, helps health systems refactor their costs, shift to be consumer-centric, and make reimbursement predictable, finds Frost & Sullivan SANTA CLARA, Calif., Feb. 11, 2021 /PRNewswire/ -- The economics of healthcare have been adversely affec...
Össur will be carbon neutral in 2021
REYKJAVIK, Iceland, Feb. 10, 2021 /PRNewswire/ -- Össur (Nasdaq: OSSR), a global leader in the orthotics and prosthetics (O&P) industry with a rich history of ground-breaking innovations, announced today that the company will be carbon neutral in 2021, its 50th anniversary year. Originally founde...
Abbott's Fast, Reliable and Convenient COVID-19 Tests Ramp Up Indonesia's Testing Capability
- Southeast Asia's most populous nation1 expands use of fastest available molecular point-of-care technology and an antigen rapid test device that needs just a nasal swab, to detect active coronavirus infections at massive scale - Delivering reliable results in minutes, Abbott's COVID-19 testing ...
VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
AUSTIN, Texas, Feb. 10, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers ...
RapidAI Acclaimed by Frost & Sullivan for Its AI-powered Modular Stroke Platform
SANTA CLARA, Calif., Feb. 10, 2021 /PRNewswire/ -- Based on its recent analysis of the global intelligent imaging analysis systems market, Frost & Sullivan recognizesRapidAI with the 2020 Global Growth, Innovation & Leadership Frost Radar Award for its artificial intelligence (AI) and machine lea...
BioVaxys and Procare Health Announce Broad Co-Development, Joint Commercialization and Marketing Collaboration for Cancer and Viral Vaccines
VANCOUVER, BC and BARCELONA, Spain, Feb. 10, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC:L MNGF)("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, and Procare Health Iberia, S.L., ofBarcelona, Spain ("Procare Health"...
Elekta's ProKnow to help standardize radiotherapy for veterans
Cloud-based ProKnow will enable peer review across Veterans Affairs network ATLANTA, Feb. 10, 2021 /PRNewswire/ -- Elekta announced today that the United States Department of Veterans Affairs (VA) National Radiation Oncology Program is poised to pair its major radiotherapy quality program with El...
I-Mab Announces China NMPA Clearance for Phase 1 Study of TJ210/MOR210 in Patients with Advanced Solid Tumors
SHANGHAI and GAITHERSBURG, Md., Feb. 10, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Center for Drug Evaluation (CDE) of the China N...
Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial
BEDMINSTER, N.J. and SINGAPORE, Feb. 10, 2021 /PRNewswire/ -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the successful completion of dosing of the first pati...
Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial
BEDMINSTER, N.J. and SINGAPORE, Feb. 10, 2021 /PRNewswire/ -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the successful completion of dosing of the first pati...
$16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial
* Commitments received for a placement of A$15,991,634 at A$0.145 per share * Significant participation from North American and European institutional and sophisticated investors * This capital raising enables proceeding with the Phase 2b PTSD trial in mid-2021 as planned and sees the Compan...
MGI's "Super Sequencer" Helps Sweden's National Pandemic Center Monitor COVID-19 Mutations
STOCKHOLM, Feb. 10, 2021 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI")'s high-throughput gene sequencer has helped the regions throughoutSweden greatly improve their COVID-19 testing capabilities from the laboratory at the National Pandemic Center located inKarolinska Institute (KI). Sweden's STV Ne...
Week's Top Stories
Most Reposted
Mastercard goes OTP-free in APAC for faster, safer online transactions
[Picked up by 326 media titles]
2024-11-06 09:00Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 309 media titles]
2024-11-12 09:00Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 284 media titles]
2024-11-12 11:00